Jaundice in children: Difference between revisions

Jump to navigation Jump to search
Line 343: Line 343:
==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
*Treatment of Jaundice is usually tailored towards the underlying etiology whether it a hematologic disease or a hepatobiliary pathology.<ref name="pmid31334972">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=31334972 | doi= | pmc= | url= }} </ref>
*[[Treatment]] of [[Jaundice]] is usually tailored towards the underlying [[etiology]] whether it a [[hematologic]] [[disease]] or a [[hepatobiliary]] [[pathology]].<ref name="pmid31334972">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=31334972 | doi= | pmc= | url= }} </ref>
*Treatment options include the following:
*[[Treatment]] options include the following:
**Phototherapy: Usually first line in neonates with severe hyperbilirubinemia to prevent neurologic sequelae.
**[[Phototherapy]]: Usually first line in [[neonates]] with severe [[hyperbilirubinemia]] to prevent [[neurologic]] [[sequelae]].
**Intravenous immunoglobulin(IVIG): helpful in hemolytic diseases and can be used in place of phototherapy and/or exchange transfusion.
**[[Intravenous]] [[immunoglobulin]](IVIG): helpful in [[hemolytic]] [[diseases]] and can be used in place of [[phototherapy]] and/or [[exchange transfusion]].
**Exchange transfusion: When the above options become inadequate to reduce levels of rising bilirubin or at the slightest clue of bilirubin encephalopathy, an exchange transfusion is done usually in the NICU/PICU and should be closely followed up for complications like:<ref name="pmid30422525">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=30422525 | doi= | pmc= | url= }} </ref>
**[[Exchange transfusion]]: When the above options become inadequate to reduce levels of rising [[bilirubin]] or at the slightest clue of [[bilirubin]] [[encephalopathy]], an [[exchange transfusion]] is done usually in the [[NICU]]/[[PICU]] and should be closely followed up for [[complications]] like:<ref name="pmid30422525">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=30422525 | doi= | pmc= | url= }} </ref>
***Cardiac arrhythmias
***[[Cardiac arrhythmias]]
***Sepsis  
***[[Sepsis]]
***Hyperkalemia
***[[Hyperkalemia]]
***Hypocalcemia
***[[Hypocalcemia]]
***Necrotising enterocolitis
***[[Necrotising enterocolitis]]
***Exchange transfusion also removes hemolytic antibodies from Rh isoimmunization and ABO incompatibility.
***[[Exchange transfusion]] also removes [[hemolytic]] [[antibodies]] from Rh [[isoimmunization]] and [[ABO]] incompatibility.
**Pharmacologic remedies such as:  
**[[Pharmacologic]] remedies such as:  
***Phenobarbitone
***[[Phenobarbitone]]
***Metalloporphyrins
***[[Metalloporphyrins]]
*Patients with pruritus especially older kids can be treated with warm baths or given antihistamines. Cholestyramine can be used in severe cases of pruritus. <ref name="pmid31334972">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=31334972 | doi= | pmc= | url= }} </ref>
*[[Patients]] with [[pruritus]] especially older kids can be treated with warm baths or given [[antihistamines]]. [[Cholestyramine]] can be used in severe cases of [[pruritus]]. <ref name="pmid31334972">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=31334972 | doi= | pmc= | url= }} </ref>
*Appropriate antiviral therapy for jaundice of viral etiology.
*Appropriate [[antiviral]] [[therapy]] for [[jaundice]] of [[viral]] [[etiology]].


===Surgery===
===Surgery===


*Surgery is the mainstay of therapy or the definitive treatment for most obstructive causes of conjugated hyperbilirubinemia.  
*[[Surgery]] is the mainstay of therapy or the definitive [[treatment]] for most obstructive causes of conjugated [[hyperbilirubinemia]].  
*Examples of procedures for common disorders are: <ref>https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/pediatrics/conjugated-hyperbilirubinemia-cholestasis/</ref>
*Examples of procedures for common [[disorders]] are: <ref>https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/pediatrics/conjugated-hyperbilirubinemia-cholestasis/</ref>
**Choledochoentersotomy for choledochal cyst
**[[Choledochoentersotomy]] for [[choledochal cyst]]
**Hepatoportoenterostomy or the Kasai procedure for biliary atresia
**[[Hepatoportoenterostomy]] or the [[Kasai procedure]] for [[biliary atresia]]
**Irrigation of the biliary tract for inspissated bile
**Irrigation of the [[biliary tract]] for [[inspissated bile]]
**Surgical drainage for common bile duct perforation  
**[[Surgical]] drainage for [[common bile duct]] [[perforation]]
*Timing of procedure with regards to the age of the child, nutritional support in the form of vitamins, and caloric replacements are extremely essential for the success of the procedure.
*Timing of [[procedure]] with regards to the age of the [[child]], [[nutritional]] support in the form of [[vitamins]], and caloric replacements are extremely essential for the success of the [[procedure]].
   
   
===Prevention===
===Prevention===


*Several etiologies may be generally difficult to prevent however the prevention of complications from jaundice is equally crucial.  
*Several etiologies may be generally difficult to [[prevent]] however the [[prevention]] of [[complications]] from [[jaundice]] is equally crucial.  
*Parents should be educated on how to recognize jaundice very early in a neonate so as to present promptly for management. Some phone apps and an icterometer are novel means of accurately detecting jaundice.<ref name="pmid30422525">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=30422525 | doi= | pmc= | url= }} </ref>
*[[Parents]] should be educated on how to recognize [[jaundice]] very early in a [[neonate]] so as to present promptly for management. Some phone apps and an icterometer are novel means of accurately detecting [[jaundice]].<ref name="pmid30422525">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume=  | issue=  | pages=  | pmid=30422525 | doi= | pmc= | url= }} </ref>
*Appropriate vaccinations should be received prior to international travels.
*Appropriate [[vaccinations]] should be received prior to [[international]] [[travels]].
*Prescribed medications should be taken in recommended dosages.
*[[Prescribed]] [[medications]] should be taken in recommended [[dosages]].
*Herbal medications should be avoided unless a physician clears it as safe.
*[[Herbal]] [[medications]] should be avoided unless a [[physician]] clears it as safe.
*Smoking, use of illicit drugs, and excess alcohol intake should be avoided in children.
*[[Smoking]], use of [[illicit drugs]], and excess [[alcohol]] intake should be avoided in [[children]] and [[pregnant]] women.
*Proper hand washing for pregnant mothers
*Proper [[hand washing]] for [[pregnant]] [[mothers]].


==References==
==References==

Revision as of 04:23, 6 November 2020

Jaundice in children Microchapters

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differential Diagnosis

Epidemiology and Demographics

Risk factors

Natural History, Complications and Prognosis

Diagnosis

Treatment

Prevention

WikiDoc Resources for Jaundice in children

Articles

Most recent articles on Jaundice in children

Most cited articles on Jaundice in children

Review articles on Jaundice in children

Articles on Jaundice in children in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Jaundice in children

Images of Jaundice in children

Photos of Jaundice in children

Podcasts & MP3s on Jaundice in children

Videos on Jaundice in children

Evidence Based Medicine

Cochrane Collaboration on Jaundice in children

Bandolier on Jaundice in children

TRIP on Jaundice in children

Clinical Trials

Ongoing Trials on Jaundice in children at Clinical Trials.gov

Trial results on Jaundice in children

Clinical Trials on Jaundice in children at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Jaundice in children

NICE Guidance on Jaundice in children

NHS PRODIGY Guidance

FDA on Jaundice in children

CDC on Jaundice in children

Books

Books on Jaundice in children

News

Jaundice in children in the news

Be alerted to news on Jaundice in children

News trends on Jaundice in children

Commentary

Blogs on Jaundice in children

Definitions

Definitions of Jaundice in children

Patient Resources / Community

Patient resources on Jaundice in children

Discussion groups on Jaundice in children

Patient Handouts on Jaundice in children

Directions to Hospitals Treating Jaundice in children

Risk calculators and risk factors for Jaundice in children

Healthcare Provider Resources

Symptoms of Jaundice in children

Causes & Risk Factors for Jaundice in children

Diagnostic studies for Jaundice in children

Treatment of Jaundice in children

Continuing Medical Education (CME)

CME Programs on Jaundice in children

International

Jaundice in children en Espanol

Jaundice in children en Francais

Business

Jaundice in children in the Marketplace

Patents on Jaundice in children

Experimental / Informatics

List of terms related to Jaundice in children

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Anaya, M.D.[2]

Synonyms and keywords: Jaundice in kids; hyperbilirubinemia

Overview

The word 'Jaundice' was derived from the french word for yellow which is jaune. Jaundice may be classified into two broad categories based on its time of onset and cause; physiologic and pathologic jaundice. Jaundice is caused by high concentrations of bilirubin in the bloodstream. A condition known as Hyperbilirubinemia. Hyperbilirubinemia can result from abnormalities in the metabolism of bilirubin which could occur at any stage from its production which is a result of the excessive breakdown of red blood cells, defects in its hepatic metabolism, and its post hepatic transport. Pathologic causes of jaundice can be classified into causes of conjugated and unconjugated hyperbilirubinemia. Differentials for jaundice are very limited however some skin discolorations in healthy individuals can look like jaundice in certain circumstances. The prevalence of jaundice varies among patient populations. In infants born at term, 60% will develop jaundice in their first-week of life. This rises to 80% in preterms. Common risk factors in the development of Jaundice in children are a family history of jaundice, family history of a child born with jaundice, hyperthyroidism in mother, medication use by mother, etc. It is essential for every clinician to note that jaundice is not always a benign condition therefore, extensive investigation of a child with jaundice is necessary to prevent severe complications. Symptoms of Jaundice in children may include the following: yellowish discoloration of the skin, sclera, and mucous membrane, time of onset, duration, and progression. Patients with jaundice usually appear yellow on the skin, mucous membranes, and/or sclera. A useful technique in assessing the severity of jaundice is by using the principle of skin discoloration progressing in a cephalo-caudal direction in newborns. Laboratory findings include measuring the serum bilirubin from a blood sample. The total and conjugated portions are measured and the unconjugated fraction is measured by subtracting the conjugated fraction from the total. Echocardiography can detect cardiac abnormalities in patients with Alagille syndrome and biliary atresia. Ultrasonography of the abdomen is used to screen for biliary atresia, choledochal cysts, or cholestatic workup in the setting of conjugated hyperbilirubinemia. Treatment options include phototherapy, intravenous immunoglobulin(IVIG), and exchange transfusion. Pharmacological options do exist. Surgery is the mainstay of therapy or the definitive treatment for most obstructive causes of conjugated hyperbilirubinemia. Several etiologies may be generally difficult to prevent however the prevention of complications from jaundice is equally crucial. Parents should be educated on how to recognize jaundice very early in a neonate so as to present promptly for management.

Historical Perspective

Classification

Pathophysiology

Causes

  • Causes of jaundice in children can be classified as follows:
 
 
 
 
 
 
 
Causes of jaundice in children
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physiologic
 
 
 
Pathologic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unconjugated hyperbilirubinemia
 
 
 
Conjugated hyperbilirubinemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemolytic
 
 
 
Non-hemolytic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•Rh incompatibility
•ABO incompatibility
•Hemoglobinopathies (Thalassemia)
•Hematomas
•Polycythemia
•Sepsis
 
 
 
•Crigler-Najjar syndrome I and II
•Gilbert syndrome
•Breast milk jaundice
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infectious
 
Obstructive
 
Drugs
 
Genetic/Metabolic
 
Storage disorders
 
Endocirnopathies
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•Viral
•Bacterial
•Parasitic
 
•Biliary atresia
•Choledochal cyst
•Inspissated bile syndrome
•Neonatal sclerosing cholangitis
•Congenital hepatic fibrosis
•Intrinsic/extrinsic mass
 
•Ceftriaxone
•Isoniazid
•Erythromycin
•Rifampin
•Sulfa drugs
•Parenteral nutrition
•Methotrexate
 
•Alpha 1 antitrypsin deficiency
•Alagille syndrome
•Cystic fibrosis
•Tyrosinemia
•Galactosemia
•Rotor syndrome
•Trisomies 18 and 21
 
•Gaucher's disease
•Niemann-pick disease
•Glycogen storage diseases
•Mucolipidoses
 
•Hypopituitarism
•Hypothyroidism
•McCune Albright syndrome
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Differentiating Jaundice in children from other Diseases

Epidemiology and Demographics

Age

Gender

Race

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 "StatPearls". 2020. PMID 30422525.
  2. https://www.rimed.org/medhealthri/2010-05/2010-05-154.pdf
  3. https://www.viapath.co.uk/news-and-press/the-birth-of-phototherapy
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 "StatPearls". 2020. PMID 31334972.
  5. https://www.rahulgladwin.com/noteblog/gastroenterology/jaundice.php
  6. Mishra S, Agarwal R, Deorari AK, Paul VK (2008). "Jaundice in the newborns". Indian J Pediatr. 75 (2): 157–63. doi:10.1007/s12098-008-0024-7. PMID 18334797.
  7. 7.0 7.1 7.2 Chee YY, Chung PH, Wong RM, Wong KK (2018). "Jaundice in infants and children: causes, diagnosis, and management". Hong Kong Med J. 24 (3): 285–292. doi:10.12809/hkmj187245. PMID 29807950.
  8. Mojtahedi SY, Izadi A, Seirafi G, Khedmat L, Tavakolizadeh R (2018). "Risk Factors Associated with Neonatal Jaundice: A Cross-Sectional Study from Iran". Open Access Maced J Med Sci. 6 (8): 1387–1393. doi:10.3889/oamjms.2018.319. PMC 6108787. PMID 30159062.
  9. https://www.nhs.uk/conditions/jaundice-newborn/complications/
  10. https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/pediatrics/conjugated-hyperbilirubinemia-cholestasis/